Thyrocare Technologies Operational Benchmarking
₹516.55-2.50%
- Market cap
- ₹8,222 crore
- P/E
- 46.6
- P/B
- 14.04
- ROE
- 28.8%
- Dividend yield
- 1.36%
Thyrocare Technologies compared with sector peers on revenue, market capitalization, valuation, and return metrics.
Thyrocare Technologies sector benchmarking & peer comparison
Operational and financial KPI comparison against sector peers.
| Company | LTP (₹) | P/E | Market Cap (₹ cr) | Div Yield | Qtr Sales (₹ cr) | ROCE % |
|---|---|---|---|---|---|---|
| Thyrocare Technologies Limited | ₹516.55 | 46.6 | 8,222 | 1.2% | 4,500 | 28.8% |
| Median (1 Cos) | ₹516.55 | 46.6 | 8,222 | 1.2% | 4,500 | 28.8% |
Source: NSE sector index filings and financial statements. Data as of 7 October 2026. How this data is compiled.
Same Data For Peers
- Dr. Lal Path Labs Ltd. operational benchmarking
- Vijaya Diagnostic Centre Limited operational benchmarking
- Metropolis Healthcare Limited operational benchmarking
- Torrent Pharmaceuticals Limited operational benchmarking
- Themis Medicare Limited operational benchmarking
- TTK Healthcare Limited operational benchmarking
Trade Thyrocare Technologies With ATS
Track THYROCARE live and place orders from the Pocket app or the Pocket Web terminal with an ATS trading and demat account.
Figures are for information only and are not investment advice or a recommendation to buy, sell or hold any security. Investments in securities are subject to market risks; read all related documents carefully before investing.